CD39 in the pathogenesis of neuro-Behçet disease: is it an immune regulator marker?

Bahrini K, Stiti A, Boughariou S, Belghith M

Open source

DOI
10.3389/fimmu.2026.1779249
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1779249,
  title = {CD39 in the pathogenesis of neuro-Behçet disease: is it an immune regulator marker?},
  author = {Bahrini K and Stiti A and Boughariou S and Belghith M},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1779249},
  url = {https://doi.org/10.3389/fimmu.2026.1779249}
}

RIS

TY  - JOUR
TI  - CD39 in the pathogenesis of neuro-Behçet disease: is it an immune regulator marker?
AU  - Bahrini K
AU  - Stiti A
AU  - Boughariou S
AU  - Belghith M
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1779249
UR  - https://doi.org/10.3389/fimmu.2026.1779249
ER  - 

APA

K, B., A, S., S, B., & M, B. (2026). CD39 in the pathogenesis of neuro-Behçet disease: is it an immune regulator marker?. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1779249

Source records